Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
AstriVax Logo
AstriVax Growth Score
52
CB Rank
86984
Heat Score
3
AstriVax aims for initial clinical validation of the platform technology, to develop a broad vaccination pipeline.
Founded
obfuscation
PrivateGrant Heverlee, Vlaams-Brabant, Belgium11-50 astrivax.com/
Clinical Trials
Medical
Overview

AstriVax
Total Funding
obfuscation
Growth Score
52
Heat Score
3

Total Funding
obfuscation
obfuscation
Grant raised
obfuscation
Growth Score52
-8 pts
in past quarter
Heat Score 3
-19 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About AstriVax

CB Rank
86984
AstriVax aims for initial clinical validation of the platform technology, to develop a broad vaccination pipeline.
Founded
obfuscation
PrivateGrant Heverlee, Vlaams-Brabant, Belgium11-50 astrivax.com/
Clinical Trials
Medical

Funding Rounds

Grant
OBF
in
obfuscation
Grant
OBF
in
obfuscation
Seed
OBF
in
obfuscation

Key People

Details

Legal Name AstriVax NV
Operating Status Active
Company Type For Profit
About the Company
AstriVax aims for initial clinical validation of the platform technology, to develop a broad vaccination pipeline.
Contact Email info@astrivax.com
Predictions & Insights

Growth Insight

See this Growth Insight
AstriVax is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Key Employee Changes

Products & Services

Plasmid-Launched Live Attenuated Virus (PLLAV) Platform
A DNA-based platform that launches self-amplifying live attenuated viral vectors and disease-targeting antigens to induce immune responses.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - AstriVax Logo
Grant - AstriVax
1
obfuscation
Agentschap Innoveren & OndernemenGrant
obfuscation
Grant - AstriVax Logo
Grant - AstriVax
1
obfuscation
Agentschap Innoveren & OndernemenGrant
obfuscation
Grant - AstriVax Logo
Grant - AstriVax
1
obfuscation
Agentschap Innoveren & OndernemenGrant
obfuscation
Grant - AstriVax Logo
Grant - AstriVax
1
obfuscation
Agentschap Innoveren & OndernemenGrant
obfuscation
Grant - AstriVax Logo
Grant - AstriVax
1
obfuscation
Agentschap Innoveren & OndernemenGrant

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - AstriVax Logo
Grant - AstriVax
1
obfuscation
Agentschap Innoveren & OndernemenGrant
obfuscation
Grant - AstriVax Logo
Grant - AstriVax
1
obfuscation
Agentschap Innoveren & OndernemenGrant
obfuscation
Grant - AstriVax Logo
Grant - AstriVax
1
obfuscation
Agentschap Innoveren & OndernemenGrant
obfuscation
Grant - AstriVax Logo
Grant - AstriVax
1
obfuscation
Agentschap Innoveren & OndernemenGrant
obfuscation
Grant - AstriVax Logo
Grant - AstriVax
1
obfuscation
Agentschap Innoveren & OndernemenGrant

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Agentschap Innoveren & Ondernemen Logo
Agentschap Innoveren & Ondernemen
Yes
Grant - AstriVax Logo
Grant - AstriVax
—
Agentschap Innoveren & Ondernemen Logo
Agentschap Innoveren & Ondernemen
Yes
Grant - AstriVax Logo
Grant - AstriVax
—
Agentschap Innoveren & Ondernemen Logo
Agentschap Innoveren & Ondernemen
Yes
Grant - AstriVax Logo
Grant - AstriVax
—
Agentschap Innoveren & Ondernemen Logo
Agentschap Innoveren & Ondernemen
Yes
Grant - AstriVax Logo
Grant - AstriVax
—
Agentschap Innoveren & Ondernemen Logo
Agentschap Innoveren & Ondernemen
Yes
Grant - AstriVax Logo
Grant - AstriVax
—
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 1 Board Members and Advisors 2 Contacts 1

Employee Profiles

Board Members and Advisors

News

News and Press

News•Jun 13, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 12, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 12, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 12, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

665
63.39%
 in past month

IT Spend

$58.8KThis year, AstriVax is projected to spend $58.8K on IT, according to Aberdeen.

Active Website Tech Count

28AstriVax is actively using 28 technologies for its website, according to BuiltWith. These include Apple Mobile Web Clips Icon, Google Tag Manager, and  WordPress.

Total IP

2AstriVax has registered 2 trademarks with the most popular class being 'Pharmaceutical, veterinary and sanitary products', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is AstriVax's headquarters? AstriVax is located in Heverlee, Vlaams-Brabant, Belgium.Who invested in AstriVax? AstriVax has 9 investors including Agentschap Innoveren & Ondernemen and  Agentschap Innoveren & Ondernemen.When was the last funding round for AstriVax? AstriVax closed its last funding round on
obfuscation
from a Grant round.Who are AstriVax's competitors? Alternatives and possible competitors to AstriVax may include Valneva, GeoVax, and  Genelux.How much funding has AstriVax raised to date? AstriVax has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(ccb7a32 1)
|